How do you know lung cancer? What is lung cancer?
Among the common symptoms of lung cancer are that lung cancer is common to diseases caused by uncontrolled growth of lung abnormal cells, including cough, cog, respiratory difficulties, fever, asthma, etc., which are among the highest in the country in terms of malignant neoplasms, with an increase in the incidence rate of 573.3 per million Chinese and more men than women, and that most patients diagnosed with lung cancers older than 65 years of age find a transfer, most often to the brain, liver and bones, leading to headaches, nausea and bone pains.
What are the cures for lung cancer? 1. The risk of second-hand smoke and lung cancer among smokers is 2.77 times that of non-smokers. 2. The history of individual tumours: Persons suffering from other malignant tumours may carry abnormal genetic mutations, which can contribute to the family history of lung cancer 3. Occupational exposure to lung cancer can be found in groups in the family history of lung cancer at the hereditary pulmonary cancer susceptibility point 4. Various special occupational exposures can increase the risk of lung cancer, including asbestos, coal smoke and soot. 5. Chronic pulmonary historical disease: the incidence of lung cancer among patients with chronic obstructive pulmonary disease, tuberculosis and pulmonary fibrosis is higher than among healthy people. Air pollution: Chemical pollution: e.g., formaldehyde, asbestos, silicon dioxide, arsenic, etc. The emphasis on early lung cancer screening (low-dose CT screening) for high-risk populations can therefore significantly improve survival rates.
By what means can lung cancer be diagnosed? Based on image results, lung cancer can be assessed in three dimensions; T (tumours): determination of the magnitude of the original tumor. Lung cancer may occur at any part of the lung N (lymphocytes): to determine whether it spreads to regional lymphoma knots. The spread to the region of lymphoma is the common characteristic M (transfer) of lung cancer: to determine whether it is transferred far away. (a) Primary lung cancer can be transferred to any organ, most commonly the brain, liver and bones understand the severity of lung cancer and non-small cell lung cancer (NSCLC), which accounts for about 80 per cent of all lung cancer and is divided into large cell cancer: large cell cancer accounts for about 9 per cent of non-small cell lung cancer, common to men and smokers, rare malignant neoplasms, pre-negative; gland cancer: the most common lung cancer type, 40 per cent – 55 per cent of lung cancer, common to women and from non-smokers, five years of survival of the patient, low target-oriented treatments show therapeutic effects, but eventually all resistant drugs;
At present, the incidence and mortality of lung cancer is at the forefront of malignant neoplasms for patients with small-cell lung cancer and squalid non-small-cell lung cancer, and immunotherapy has led to new breakthroughs in survival gains, as well as a focus on early screening for lung cancer (low-dose CT screening) for high-risk populations, which can significantly improve survival rates. Immunisation treatment is an important first-line treatment for patients with non-surgery lung cancer in the middle and late stages, as well as for those with post-pulmonary cancer; it also benefits more from survival as a new, assisted whole-body treatment option for surgical non-small cell lung cancer patients and long-term immunization. People with advanced lung cancer should receive two years of immunization.
